NU-MED PLUS, INC. (NUMD) Return on equity 2017–2020
NU-MED PLUS, INC. (NUMD) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-429.5%FY2020 · since FY2017: 5241.6% → -429.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | -429.5% | — |
| FY2018 | -2449.9% | -7691.5 pp |
| FY2017 | 5241.6% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More NUMD financial trends
NUMD RevenueNUMD Net incomeNUMD Net marginNUMD Gross profitNUMD Gross marginNUMD Operating incomeNUMD Operating marginNUMD Operating cash flowNUMD Free cash flowNUMD Capital expendituresNUMD Stock buybacksNUMD Dividends paidNUMD Total assetsNUMD Total liabilitiesNUMD Shareholders’ equityNUMD overview →